In males, no significant differences in OPG and RANKL levels were found in cancer-free individuals or those with new onset prostate cancer, which is also related to sex hormones, or other types of cancer (Figure 5A, 5B). This evidence concerns the gene TNFSF11 and prostate carcinoma.